Table 1.
Chemical Characterization of NDGa
| NDG | NDA | Gd–C5–COOH | |
|---|---|---|---|
| Gd(III) content (μmol mg−1) | 1.5 ± 0.2 | n.a. | n.a. |
| primary amines (μmol mg−1) | 0.2 ± 0.1 | 1.6 ± 0.3 | n.a. |
| r1 at 1.4 T (mM−1 s−1) | 11.1 ± 0.9 | n.a. | 6.4 ± 0.8 |
| r2 at 1.4 T (mM−1 s−1) | 16.1 ± 0.9 | n.a. | 10.4 ± 0.8 |
| r1/r2 at 1.4 T | 0.69 | n.a | 0.61 |
| r1 at 7 T (mM−1 s−1) | 11.5 ± 0.8 | n.a | 4.8 ± 0.7 |
| r2 at 7 T (mM−1 s−1) | 15.5 ± 0.8 | n.a. | 8.1 ± 0.7 |
| r1/r2 at 7 T | 0.74 | n.a. | 0.59 |
Gd(III) content of NDG is quantified by ICP-MS. Peptide coupling is verified by comparing primary amine content in NDA (pre-coupling) and NDG (post-coupling). Primary amine content is assessed using a modified Kaiser test41 (see Figure S4). The number of primary amines is lower in NDG compared to NDA as a majority of surface amines are modified to amides post-chelate coupling. r1 for NDG is two-fold greater, and r2 is 1.5-fold greater, than Gd–C5–COOH at 1.4 T. Unlike other nanoformulations bearing Gd(III) that suffer from less efficient relaxation kinetics at higher field strengths, the longitudinal relaxivity of NDG and r1/r2 ratio are maintained at 7 T. n.a. = not applicable.